Context: The myokine irisin may increase energy expenditure and affect metabolism.
D uring the previous decade, both adipose tissue and skeletal muscle have been identified as endocrine organs secreting hormones called adipokines and myokines, respectively (1) . It has been proposed that there is a muscleadipose tissue cross talk (2) , critical for the regulation of body weight and metabolism, but the specific metabolic pathways and mediators remain elusive. Irisin, a newly discovered myokine induced by exercise, stimulates browning of adipose tissue and may contribute to muscle-adipose tissue cross talk (3) . Circulating irisin results from C-terminal cleavage of the fibronectin type III domain containing (FNDC)-5 transmembrane protein, which is the product of FNDC5 gene (3, 4) . This process is induced by the peroxisome proliferatoractivated receptor-␥ coactivator-1a (3) . Irisin, by acting through a currently unknown receptor, induces the browning of white adipose tissue, thereby increasing thermogenesis and possibly improving glucose homeostasis (4 -8) . However, it has recently been reported that irisin is also produced by adipocytes (2, 6) , whereas circulating irisin was found to be increased in insulin resistance states and metabolic syndrome (9, 10) . Thus, irisinemia has been proposed as a new promising concept to monitor metabolic disorders (11) , and irisin appears as an appealing potential therapeutic target for obesity and metabolic disorders (6, 12, 13) . Nevertheless, the physiological determinants of irisin and its pattern of secretion remain largely unknown.
The main aim of this study was to elucidate irisin physiology in humans and more specifically to evaluate the following: 1) the association between irisin levels and circulating levels of other adipokines (leptin, adiponectin) and anthropometric and metabolic parameters as well as eating and exercise habits in healthy, young individuals; 2) the effect of food intake and exercise on circulating irisin levels; 3) whether there is a day-night fluctuation of irisin levels; and/or 4) a potential gender dimorphism of irisin levels.
Patients and Methods

Patients
One hundred twenty-two apparently healthy, young Caucasian medical students of both sexes (50% males) were included in this study, which consisted of four substudies: an observational, cross-sectional study (main study), an additional 24-hour prospective observational study (day-night rhythm substudy) and two prospective interventional studies (mixed meal substudy and exercise substudy). Exclusion criteria were as follows: 1) body mass index (BMI) less than 20 kg/m 2 or greater than 30 kg/m 2 ; 2) considerable weight loss or gain (Ͼ5%) during the previous 6 months, 3) a change in physical activity during the previous 3 months; 4) excessive exercise within the last 24 hours; 5) myopathy or any systematic disorder that may affect the skeletal muscles; 6) any musculoskeletal injury or surgical procedure 6 months prior to baseline; and 7) history of or concomitant medications that could affect muscle or lipid metabolism, including anticonvulsant, corticosteroids, nonsteroidal antiinflammatory drugs, and statins. The study was approved by the Ethics Committee of 424 General Military Hospital and was in accordance with the Declaration of Helsinki and the International Conference on Harmonization for Good Clinical Practice. Written informed consent was obtained from all the participants.
Methods
Main study
Baseline assessment consisted of detailed medical history (including smoking status and day of menstrual cycle in females), weight, height, and waist and hip circumference measurements as well as BMI and waist to hip ratio (WHR) calculation. After a standardized dinner and an overnight fast, morning (8:00 -9:00 AM) venous blood samples were obtained from all the participants. Serum levels of glucose, total cholesterol, triglycerides, high-density lipoprotein-cholesterol, uric acid, creatinine, aspartate aminotransferase, alanine aminotransferase, ␥-glutamyl transferase, total alkaline phosphatase, lactate dehydrogenase, and creatine kinase (CK) were measured within 1 hour after blood drawing using standard methods. Low-density lipoprotein-cholesterol was calculated by the Friedewald formula. Additional blood samples were centrifuged immediately and serum was separated and stored at Ϫ30°C. These samples were sent to the laboratory of the Division of Endocrinology at Beth Israel Deaconess Medical Center (Boston, Massachusetts) at the end of the study for the measurement of irisin [ELISA; Phoenix Pharmaceuticals; catalog number EK-067-52; sensitivity 9.3 ng/mL, intraassay coefficient of variation (CV) 4%-6%, interassay CV 8%-10%], leptin (RIA; Millipore Corp; sensitivity 0.437 ng/mL, intraassay CV 3.4 -8.3%, interassay CV 3.6 -6.2%), adiponectin (RIA; Millipore Corp; sensitivity 1 ng/mL, intraassay CV 1.8 -6.2%, interassay CV 6.9 -9.3%), and insulin (Immulite 1000; Siemens Healthcare Diagnostics; sensitivity 1 ng/mL, intraassay CV 5.2-6.4%, interassay CV 5.9 -8.0%). All study samples were assayed in duplicate.
To evaluate insulin resistance, the homeostatic model of assessment-insulin resistance (HOMA-IR) was calculated by the formula: HOMA-IR ϭ [insulin (milliunits per liter) ϫ glucose (millimoles per liter)]/22.5. Body composition [percentage of total body fat (TBF), lean body mass (LBM), and total body water] were measured by bioelectrical impedance analysis using the Bodystat 1500 (Bodystat Ltd). Participants were briefed by an experienced nutritionist-dietitian, who explained them the questions provided, trained them in portion acknowledgment, and a validated food frequency questionnaire [FFQ; semiquantitative FFQ (14)] as well as physical activity questionnaire [a modified version of International Physical Activity Questionnaire (IPAQ) (14) ] were completed for every one of them. The MedDiet score (15) as well as energy and macronutrients intake (13) were calculated on the basis of the FFQ data. The score derived from IPAQ data was used to classify the participants as having high, moderate, or low physical activity.
Day-night rhythm substudy
Twenty individuals (10 males and 10 females), randomly selected from the main study, were hospitalized and closely monitored for 24 hours. Throughout the 24-hour period, the participants were at rest, avoiding exercise and sleep deprivation, and were receiving an individually isocaloric, balanced diet. A forearm iv catheter was placed and blood samples were obtained every 3 hours (9:00 AM, 12:00 PM, 3:00 PM, 6:00 PM, 9:00 PM, 12:00 AM, 3:00 AM, and 6:00 AM) for the measurement of irisin. Serum cortisol (Immulite 1000; Siemens Healthcare Diagnostics; sensitivity 0.2 g/dL, intraassay CV 5.8%-8.8%, interassay CV 6.3%-10.0%) was used as a positive control measurement and IGF-binding protein 3 (IGF-BP3; Immulite 1000; Siemens Healthcare Diagnostics; sensitivity 0.1 g/mL, intraassay CV Figure 1 . Scatter plots presenting the correlation between circulating irisin levels and lean body mass at baseline, separately for men and women. doi: 10.1210/jc.2014-1367 jcem.endojournals.org 3.5%-5.6%, interassay CV 7.5%-9.9%) as a negative control measurement. CK was also measured at all time points.
Mixed-meal substudy
A subpopulation of 36 individuals randomly selected from the main study participated in a mixed-nutrient stimulation study receiving a standardized mixed meal (Fresubin Original Drink; Fresenius; energy density 1.0 kcal/mL, carbohydrates 55%, protein 15%, fat 30%) in two different quantities: 125 mL (n ϭ 18) and 250 mL (n ϭ 18). Blood was obtained before and 30 minutes after meal consumption. Serum studied parameters were measured as described at the main study.
Exercise substudy
Twenty moderately trained participants according to IPAQ classification (10 males and 10 females) from the main study performed a 30-minute aerobic exercise session (outdoor running at a constant pace). Blood was obtained before and at the end of the 30-minute exercise. Serum parameters were measured as described at the main study.
Power analysis
An a priori power analysis was performed, setting as primary outcome the correlations between irisin and other parameters (bivariate normal model; two tailed). This analysis showed that, for correlation H1 ϭ 0.32 (corresponding to coefficient of determination 2 ϭ 0.1), type A error probability of 0.05, and power of 95%, 121 patients should be recruited. A priori power analysis was performed by G*Power software version 3.1.5.1 (University of Heinrich-Heine, Dusseldorf, Germany).
Statistical analysis
Data for continuous variables are presented as mean Ϯ SEM. Data for categorical variables are presented as numbers and/or percentages. A Kolmogorov-Smirnov test was used to check the normality of distribution of the continuous variables. Independent samples t test or Mann-Whitney U test was used for between group comparisons, in cases of two groups of continuous variables. Oneway ANOVA or Kruskal-Wallis test was used in cases of more than two groups of continuous variables. In case of statistically significant difference in ANOVA or Kruskal-Wallis test, Bonferroni post hoc adjustment was used for multiple pairwise comparisons. An analysis of covariance was used to adjust between group differences for potential confounders. Repeated-measures analysis of covariance was used to adjust paired measurements for potential confounders. A 2 test or Fischer's exact test was used to compare categorical variables. Spearman's coefficient (rs) was used for unadjusted correlations. Partial coefficient was used for binary correlations adjusted for potential confounders. Multiple linear regression analysis («enter» method) was used to identify variables independently associated with serum irisin levels. Variables that were not normally distributed were logarithmically transformed for the need of this analysis. The analyses were on treatment. A twosided value of P Ͻ .05 was considered statistically significant in all the above tests. Statistical analysis was performed with SPSS 21.0 for Macintosh (IBM Corp).
Results
Main Study
The descriptive characteristics of the sum of participants included in the main study (n ϭ 122) and compar- ative data between males and females are presented in Table 1 . There was no statistically significant difference in irisin levels between males and females (91.3 Ϯ 4.8 and 81.9 Ϯ 3.0 ng/mL, respectively; P ϭ .11); however, after adjustment for LBM, estimated irisin levels were significantly lower in males than females (estimated marginal means: 72.5 Ϯ 6.4 and 100.8 Ϯ 6.3 ng/mL, respectively; P ϭ .02). As expected, adiponectin and leptin were higher, whereas insulin and HOMA-IR were lower in females than males. Regarding dietary habits, there was no evidence that total caloric or macronutrient intake and/or any food group was associated with circulating irisin levels. Furthermore, circulating irisin, leptin, and adiponectin were not significantly correlated with the dietary quantity (grams per day) of carbohydrates, proteins, fat, fibers, or alcohol as assessed by the FFQ. Similarly, irisin levels were not statistically different among the eight groups of different MedDiet scores (0 -7; P ϭ .88) and/or when participants were classified according to the Med Diet score in a dichotomous manner, eg, in those with MedDiet score 3 or less and MedDiet score greater than 3 (87.3 Ϯ 4.1 and 85.5 Ϯ 3.6 ng/mL, respectively; P ϭ .70). Similar results were observed, when the participants were divided into three groups according to their Med Diet score [(0 -2 vs 3-4 vs 5-7): irisin levels 92.3 Ϯ 6.3 vs 84.2 Ϯ 3.5 vs 82.5 Ϯ 3.7 ng/mL; P ϭ .20].
Regarding physical activity habits, there was no statistically significant difference in irisin levels or any other study's variable among individuals with low, moderate, or high physical activity (84.5 Ϯ 4.7, 86.2 Ϯ 5.0, and 91.0 Ϯ 8.0 ng/mL, respectively; P ϭ .66). As expected, LBM, was higher, whereas TBF was lower in individuals with high physical activity (data not shown).
In unadjusted correlations, circulating irisin was positively correlated with LBM (r s ϭ 0.28; P ϭ .002: Figure 1 ), total body water (r s ϭ 0.25; P ϭ .01), glucose (r s ϭ 0.24; P ϭ .01), and uric acid (r s ϭ 0.26; P ϭ .004) but not with waist or hip circumference, WHR, BMI, TBF, HOMA-IR, insulin, leptin, adiponectin, or other metabolic parameters (data not shown).
In multiple linear regression analysis (Table 2) , irisin levels were independently and positively associated with LBM and female gender but only marginally negatively with TBF. Female gender, higher LBM, and lower TBF were associated with higher irisin independently from age, HOMA-IR, leptin, and adiponectin. Based on the sequential models of linear regression analysis (Table 2) , the major determinant of the models is LBM.
Day-night rhythm substudy
Twenty individuals (10 males) participated in the daynight rhythm substudy. Circulating irisin levels revealed a day-night rhythm (P for trend Ͻ.001; Figure 2 ). Serum irisin displayed a variation of approximately 29% throughout the day, reaching its nadir levels at 6:00 AM and zenith levels at 9:00 PM. The day-night rhythm of circulating irisin tended to follow an inverse pattern than the one observed in serum cortisol (74% variation; nadir at 12:00 AM and zenith at 9:00 AM; used as positive control for Figure 2 ), whereas, as expected, IGF-BP3 followed a relatively flat pattern (used as negative control; Figure 2 ). Notably, serum CK showed a progressive decrease from 9:00 AM to 3:00 AM (44% variation; zenith at 9:00 AM and nadir at 3:00 AM; Figure 2 ), exhibiting a pattern quite different from that of irisin. There were no differences between genders in day-night rhythm of the above parameters.
Mixed-meal substudy
Eighteen individuals received 125 mL and another 18 received 250 mL of the standardized mixed meal. Age and anthropometric characteristics of either group did not differ statistically from those of the total cohort (Table 1) . Irisin levels were not significantly changed after consuming either 125 or 250 mL of the standardized meal (Table  3) . Similarly, creatinine, CK, lactate dehydrogenase, serum lipids and liver function tests were minimally or not affected (data not shown). On the other hand, glucose, insulin, and HOMA-IR were significantly increased after consuming either 125 or 250 mL of the standardized meal (Table 3 ). There were no significant differences between males and females in irisin levels either at baseline or postprandial (Table 3) . No time gender interaction was observed in irisin or other parameters, apart from glucose levels at the 250 mL test, which were higher in men than women 30 mL after the 250 mL of standardized meal (Table 3) .
Exercise substudy
Twenty individuals participated in the exercise substudy. None of them terminated the exercise earlier than required. Age and anthropometric characteristics of the participants did not statistically differ from those of the total cohort (Table 1) . Irisin levels were significantly increased at the end of exercise (84.1 Ϯ 10.0 vs 105.8 Ϯ 14.3 ng/mL; P Ͻ .001). There were no significant differences between males and females in irisin levels either at baseline or at the end of exercise.
Discussion
Irisin, a myokine potentially induced by acute exercise that may increase energy expenditure and thus play an important role in obesity and metabolic disorders, has been proposed to be associated with correlates of metabolic disorders (11) and as a potential future therapeutic target (6) . However, its physiology in humans remains largely unknown. In this study in young healthy individuals, irisin levels were higher in females than males after adjustment for LBM. LBM was a strong positive predictor of irisin levels, whereas TBF was an inverse predictor of marginal significance. Our findings suggest a day-night rhythm of irisin secretion. Food intake had no effect on circulating irisin levels, whereas exercise increased them acutely.
The positive association of irisin with LBM in young, healthy individuals in our study was independent of age, gender, insulin resistance, leptin, and adiponectin and was the major determinant of the models in multiple linear regression analysis. This finding supports the view that irisin is mainly secreted by the muscle, at least in young and apparently healthy individuals. Our results are in accordance with the positive correlation with LBM (7, 10, 16) and biceps circumference (as a surrogate marker of muscle mass) (7) that have been previously reported in healthy subjects with a wide range of BMI.
Importantly, after adjustment for LBM, higher irisin levels were found in females than males, indicating gender dimorphism of irisin. Furthermore, female gender was independently associated with irisin levels. Higher irisin levels were also previously reported in healthy girls compared with boys (17) . On the other hand, in another study, obese men had higher irisin than women (18); however, in that Data are presented as mean Ϯ SEM for continuous variables and frequencies for categorical variables. a P value for between baseline and 30-minute comparisons for the sum of participants; P value for time gender interaction is in parentheses. b P value for between gender comparisons at each time point. study irisin differences were adjusted for BMI, not LBM. Finally, no gender difference in adipocytes' FNDC5 expression was reported in middle-aged, healthy adults in another study (6) . Irisin has been proposed to be secreted not only by myocytes but also by adipocytes (2, 6) , although possibly in considerably lower quantity (6) . FNDC5/irisin secretion from the adipose tissue was significantly higher in obese rats compared with lean ones (2) , and a positive correlation with fat mass was reported in healthy individuals with a wide range of BMI (10) and obese subjects (18) . On the contrary, a marginal inverse association between TBF and irisin levels was observed in our population, which is in accordance with the results of Moreno-Navarrete et al (6) . Although no solid explanation exists for this discrepancy, population characteristics, including age, body composition and metabolic status/comorbidities, may be accounted for. It may be speculated that skeletal muscle is the main source of circulating irisin under normal metabolic conditions, whereas adipose tissue may produce and thus partly determine irisin levels in the obese; in line with this speculation, irisin levels were previously reported to be higher in lean than obese individuals (8) . This is possibly the reason that irisin was not correlated with BMI or WHR in our study. Our participants had normal mean BMI, and therefore, irisin is not anticipated to be significantly affected by the relatively low variation of BMI or waist circumference. In the literature, both positive (5, 7, 10) and negative correlations with BMI (6, 8, 19) and WHR (6) have been reported, depending on the studied population.
In rats, short-term periods of endurance exercise training induced FNDC5/irisin secretion by sc and visceral adipose tissue (2) . In humans, acute aerobic exercise transiently increased circulating irisin at 30 minutes (7) , 45 minutes (20) , and 54 minutes (21) . On the other hand, exercise training had no effect on FNDC5 gene expression in the muscle or fat tissue of pigs (22) . Additionally, other investigators have claimed that circulating irisin levels (16, 20, (23) (24) (25) and FNDC5 expression/irisin mRNA levels in the muscle (16, 20, 24, 25) are not increased after shortor long-term aerobic or strength endurance training. Based on the IPAQ scores, we observed no association between exercise habits and circulating irisin. Although no association between physical activity and irisin levels is expected on a long-term basis, potential questionnairerelated biases may have affected this result. On the other hand, a 30-minute aerobic exercise acutely increased irisin levels in healthy students with moderate physical activity.
We also report a day-night rhythm of irisin secretion, with its lowest levels early in the morning and its peak levels around 9:00 PM. This pattern of secretion is the opposite of the one reported for fibroblast growth factor 21 (26) , another product of muscle and adipose tissue, which mediates cold-induced thermogenesis in humans (26) . No explanation for this can be derived from the present study. Neural, hormonal, or other factors may play a role in irisin's day-night rhythm, whereas the gradual increase of environmental temperature during the day could explain the reported diurnal reduction of cold-induced fibroblast growth factor 21 levels (26) . A clinical implication of irisin's day-night rhythm is that time of blood draw should be taken into consideration for the standardization of irisin's normal range and for evaluating irisin's results. The day-night-rhythm of CK in our study was identical to the pattern seen during constant bed rest (27) , although our participants, whereas avoiding physical activity, were not constantly in bed. This similarity between the two studies implies a day-night rhythm of CK, irrespective of physical activity. The distinct patterns of day-night rhythm observed for irisin and CK (Figure 2) do not support the hypothesis that irisin leaks from muscle cells in response to muscle damage. Nevertheless, this remains to be elucidated by future studies specifically designed to address this Circulating irisin levels were not correlated with the dietary patterns or habits in terms of quantity or quality in this study, a finding in accordance with previous data (28) . Furthermore, in our mixed-meal substudy, a standardized meal in two escalating quantities did not affect irisin levels, in accordance with a previous study in a middle-aged population of higher BMI (7) . Consequently, irisin levels do not seem to be affected by food ingestion. No correlation between irisin and leptin or adiponectin was observed in our population. In obese rats low and high physiological doses of leptin had no effect on peroxisome proliferatoractivated receptor-␥ coactivator-1␣ mRNA or FNDC5 mRNA levels in myotubes (29) , whereas in human muscle and adipose tissue, FNDC5 gene expression was negatively associated with leptin expression (6) . In populations that were older and of higher BMI compared with our study, irisin was not associated with leptin (7, 8, 18) ; regarding adiponectin, some authors reported a negative correlation with irisin (7), whereas others reported no correlation (8) . More studies are needed to elucidate the relationship of irisin with adipokines or other parameters, translating into the cross talk between skeletal muscle and adipose tissue, insulin resistance, and hepatic and lipid metabolism.
Our study has certain strengths but also some limitations. The strengths include its relatively large sample size of apparently healthy individuals, the homogeneity of the population in terms of age, BMI, health status and living conditions, and the multifaceted investigation of irisin's physiological role, through evaluation of the effect of food and physical activity, both by validated questionnaires and interventions (standardized mixed meal and short term exercise, respectively). This is also the first report for day-night rhythm of irisin. A limitation of this investigation is the cross-sectional design and hence observational nature of our main study. Another limitation was the fact that body composition was measured by bioelectrical impedance analysis rather than dual-energy X-ray absorptiometry, which is considered to be the gold standard for evaluating lean mass and fat mass. Furthermore, data on the intensity of the exercise intervention (such as maximal oxygen uptake) were not available for the exercise substudy.
In conclusion, our data indicate that muscles are the main source of circulating irisin, at least in young healthy individuals, with higher levels in females, when adjusting for LBM. Circulating irisin has a day-night variation with the lowest levels at 6:00 AM and the highest at 9:00 PM. Irisin levels are not affected by physical activity status but are increased acutely after a short-term aerobic exercise in individuals with moderate physical activity. Finally, dietary habits or food intake do not influence circulating irisin levels.
